CGON vs COPART
CG Oncology, Inc. Common stock (CGON) versus COPART (COPART) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
COPART (COPART) common stock.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
COPART does not have a complete income-statement cache yet.
CGON currently screens at market cap $4.74B.
Not investment advice. Open the CGON and COPART stock pages for the full models.
Not investment advice.